SANA Scorecard | Sana Biotechnology, Inc.

Sana Biotechnology, Inc. (SANA) Scorecard

2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

10/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q21/3	WinSANA / S&P 21.18% / 15.20%	LoseSANA / S&P SANA unavailable / 15.00%	LoseSANA / S&P -28.30% / 50.40%
2026-Q10/3	LoseSANA / S&P -29.24% / -4.33%	LoseSANA / S&P SANA unavailable / 11.30%	LoseSANA / S&P 5.68% / 27.70%
2025-Q41/3	WinSANA / S&P 14.65% / 2.65%	LoseSANA / S&P SANA unavailable / 9.00%	LoseSANA / S&P -16.38% / 13.40%
2025-Q31/3	WinSANA / S&P 30.04% / 8.12%	LoseSANA / S&P SANA unavailable / 4.61%	LoseSANA / S&P -30.71% / 13.45%
2025-Q21/3	WinSANA / S&P 62.50% / 10.94%	LoseSANA / S&P SANA unavailable / 4.83%	LoseSANA / S&P -7.83% / 10.63%
2025-Q11/3	WinSANA / S&P 3.07% / -4.27%	LoseSANA / S&P SANA unavailable / 4.98%	LoseSANA / S&P -42.48% / 10.57%
2024-Q40/3	LoseSANA / S&P -60.82% / 2.41%	LoseSANA / S&P SANA unavailable / 5.25%	LoseSANA / S&P -21.09% / 6.15%
2024-Q30/3	LoseSANA / S&P -23.81% / 5.89%	LoseSANA / S&P SANA unavailable / 5.89%	LoseSANA / S&P -2.78% / 6.11%
2024-Q20/3	LoseSANA / S&P -45.40% / 4.28%	LoseSANA / S&P SANA unavailable / 5.38%	LoseSANA / S&P -39.15% / 5.12%
2024-Q11/3	WinSANA / S&P 145.10% / 10.56%	LoseSANA / S&P SANA unavailable / 5.71%	LoseSANA / S&P -9.47% / 5.59%
2023-Q40/3	LoseSANA / S&P 5.43% / 11.69%	LoseSANA / S&P SANA unavailable / 6.81%	LoseSANA / S&P 2.80% / 7.78%
2023-Q30/3	LoseSANA / S&P -35.07% / -3.27%	LoseSANA / S&P SANA unavailable / 7.52%	LoseSANA / S&P -11.11% / -5.03%
2023-Q22/3	WinSANA / S&P 82.26% / 8.74%	LoseSANA / S&P SANA unavailable / 9.50%	WinSANA / S&P 15.95% / -8.57%
2023-Q11/3	LoseSANA / S&P -17.22% / 7.50%	LoseSANA / S&P SANA unavailable / 10.77%	WinSANA / S&P 46.96% / -15.69%
2022-Q40/3	LoseSANA / S&P -34.17% / 7.56%	LoseSANA / S&P SANA unavailable / 11.88%	LoseSANA / S&P SANA unavailable / -17.99%
2022-Q30/3	LoseSANA / S&P -6.69% / -4.88%	LoseSANA / S&P SANA unavailable / 13.47%	LoseSANA / S&P SANA unavailable / -1.41%
2022-Q20/3	LoseSANA / S&P -22.15% / -16.10%	LoseSANA / S&P SANA unavailable / 13.71%	LoseSANA / S&P SANA unavailable / 11.04%
2022-Q10/3	LoseSANA / S&P -46.64% / -4.60%	LoseSANA / S&P SANA unavailable / 15.97%	LoseSANA / S&P SANA unavailable / 42.23%
2021-Q40/3	LoseSANA / S&P -31.26% / 11.03%	LoseSANA / S&P SANA unavailable / 15.00%	LoseSANA / S&P SANA unavailable / 96.40%
2021-Q31/3	WinSANA / S&P 14.55% / 0.58%	LoseSANA / S&P SANA unavailable / 10.77%	LoseSANA / S&P SANA unavailable / 69.42%
2021-Q20/3	LoseSANA / S&P -41.26% / 8.55%	LoseSANA / S&P SANA unavailable / 6.58%	LoseSANA / S&P SANA unavailable / 51.81%
2021-Q10/3	LoseSANA / S&P SANA unavailable / 6.17%	LoseSANA / S&P SANA unavailable / -1.06%	LoseSANA / S&P SANA unavailable / 7.39%
2020-Q40/3	LoseSANA / S&P SANA unavailable / 12.15%	LoseSANA / S&P SANA unavailable / -3.72%	LoseSANA / S&P SANA unavailable / -33.42%
2020-Q30/3	LoseSANA / S&P SANA unavailable / 8.93%	LoseSANA / S&P SANA unavailable / -2.04%	LoseSANA / S&P SANA unavailable / -27.10%
2020-Q20/3	LoseSANA / S&P SANA unavailable / 20.54%	LoseSANA / S&P SANA unavailable / -0.46%	LoseSANA / S&P SANA unavailable / -27.11%
2020-Q10/3	LoseSANA / S&P SANA unavailable / -19.60%	LoseSANA / S&P SANA unavailable / 3.47%	LoseSANA / S&P SANA unavailable / -14.75%
2019-Q40/3	LoseSANA / S&P SANA unavailable / 9.07%	LoseSANA / S&P SANA unavailable / 5.36%	LoseSANA / S&P SANA unavailable / 2.99%
2019-Q30/3	LoseSANA / S&P SANA unavailable / 1.70%	LoseSANA / S&P SANA unavailable / 5.02%	LoseSANA / S&P SANA unavailable / 0.21%
2019-Q20/3	LoseSANA / S&P SANA unavailable / 4.30%	LoseSANA / S&P SANA unavailable / 6.64%	LoseSANA / S&P SANA unavailable / 8.65%
2019-Q10/3	LoseSANA / S&P SANA unavailable / 13.65%	LoseSANA / S&P SANA unavailable / 8.12%	LoseSANA / S&P SANA unavailable / 14.29%
2018-Q40/3	LoseSANA / S&P SANA unavailable / -13.52%	LoseSANA / S&P SANA unavailable / 9.05%	LoseSANA / S&P SANA unavailable / 18.23%
2018-Q30/3	LoseSANA / S&P SANA unavailable / 7.71%	LoseSANA / S&P SANA unavailable / 10.21%	LoseSANA / S&P SANA unavailable / 19.06%
2018-Q20/3	LoseSANA / S&P SANA unavailable / 3.43%	LoseSANA / S&P SANA unavailable / 9.03%	LoseSANA / S&P SANA unavailable / 14.46%
2018-Q10/3	LoseSANA / S&P SANA unavailable / -0.76%	LoseSANA / S&P SANA unavailable / 7.68%	LoseSANA / S&P SANA unavailable / 12.46%
2017-Q40/3	LoseSANA / S&P SANA unavailable / 6.64%	LoseSANA / S&P SANA unavailable / 7.03%	LoseSANA / S&P SANA unavailable / 13.82%
2017-Q30/3	LoseSANA / S&P SANA unavailable / 4.48%	LoseSANA / S&P SANA unavailable / 5.68%	LoseSANA / S&P SANA unavailable / 17.57%
2017-Q20/3	LoseSANA / S&P SANA unavailable / 3.09%	LoseSANA / S&P SANA unavailable / 4.83%	LoseSANA / S&P SANA unavailable / 17.74%
2017-Q10/3	LoseSANA / S&P SANA unavailable / 6.07%	LoseSANA / S&P SANA unavailable / 3.67%	LoseSANA / S&P SANA unavailable / 13.32%
2016-Q40/3	LoseSANA / S&P SANA unavailable / 3.82%	LoseSANA / S&P SANA unavailable / 2.09%	LoseSANA / S&P SANA unavailable / 7.05%
2016-Q30/3	LoseSANA / S&P SANA unavailable / 3.85%	LoseSANA / S&P SANA unavailable / 0.20%	LoseSANA / S&P SANA unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	SANA total return	S&P 500 Total Return Index
Total return	33.66%	20.78%
Annualized return	33.66%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	SANA total return	S&P 500 Total Return Index
Total return	-83.45%	83.14%
Annualized return	-30.22%	12.86%

10Y · 2021-02-04 to 2026-08-27

Metric	SANA total return	S&P 500 Total Return Index
Total return	-88.35%	319.30%
Annualized return	-19.34%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Candel Therapeutics, Inc. (CADL)	United States	$0.885B	-8.86
Attovia Therapeutics, Inc. (ATTO)	United States	$0.828B
Odyssey Therapeutics, Inc. (ODTX)	United States	$0.960B
Solid Biosciences Inc. (SLDB)	United States	$0.802B	-5.07
Cullinan Therapeutics, Inc. (CGEM)	United States	$0.993B	-5.72
Monte Rosa Therapeutics, Inc. (GLUE)	United States	$1.002B	-12.81
4D Molecular Therapeutics, Inc. (FDMT)	United States	$0.733B	-4.10
MeiraGTx Holdings plc (MGTX)	United States	$1.061B	16.10
Vor Biopharma Inc. (VOR)	United States	$1.091B	1.60
Aura Biosciences, Inc. (AURA)	United States	$0.639B	-5.61